July 27, 2020
A Massachusetts federal judge has tossed a securities class action alleging biopharmaceutical company Aveo and its executives misled investors about possible federal approval of a cancer drug, saying the company "explicitly warned the public" about the uncertainty of a clinical trial.
December 05, 2019
Investors who allege they were misled by Aveo Pharmaceuticals Inc. as to the effectiveness of its flagship children's cancer drug told a Massachusetts federal judge Wednesday that they have done enough to defeat Aveo's bid to get the suit tossed.
May 06, 2019
Pomerantz LLP was named lead counsel and Andrews DeValerio LLP liaison counsel Monday in a proposed class action accusing Aveo Pharmaceuticals Inc. and its officers of misleading investors about the effectiveness of a candidate cancer drug just before a stock price plunge.
April 22, 2019
A proposed class action accusing embattled Aveo Pharmaceuticals Inc., its CEO and two others of misleading investors ahead of a sharp January stock drop was moved to Massachusetts federal court Monday after the company's unopposed bid to transfer the suit from New York.